Literature DB >> 17725720

Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.

James Kurtz1, Shalini Seetharaman, Nicholas Greco, Gary Moroff.   

Abstract

BACKGROUND: The testing of cord blood (CB) progenitor and stem cell units for transplantation suitability involves enumeration of total nucleated cells before freezing. CD34+ cell counts may also be a means of determining suitability. Studies have been conducted to evaluate how specific storage conditions influence cell counts. STUDY DESIGN AND METHODS: CB units were processed by hydroxyethyl starch volume reduction. Cryopreserved-thawed samples were diluted 1:3 without washing. CD34+ cells were measured with three commercially available assay methods. In specific studies, apoptosis-indicating reagents were included. CB units were analyzed for nucleated cells, aldehyde dehydrogenase-containing cells, and progenitor colonies.
RESULTS: CD34+ cell levels and nucleated cells were retained during storage in test tubes at 1 to 6 degrees C for 3 days. Cryopreserved-thawed samples showed a reduction in CD34+ cells relative to prefreeze levels with the largest decrease with the Stem-Kit (Beckman Coulter) restricted gating procedure. Prefreeze samples contained minimal numbers of presumed apoptotic cells detected with 7-aminoactinomycin D or SYTO16, but after cryopreservation-thawing there was an increase. Nucleated cell levels determined with a hematology analyzer or flow cytometry were reduced after thawing. Cryopreservation-thawing reduced the percentage of CD34+ cells positive for the presence of aldehyde dehydrogenase and the number of progenitor colonies. These differences were significant.
CONCLUSION: These studies indicate that CD34+ cell counts were maintained when CB samples were stored at 1 to 6 degrees C in test tubes for 3 days. Cryopreservation-thawing resulted in changes in a number of parameters including the percentage of CD34+ cells that were aldehyde dehydrogenase(+) and the number of 7-aminoactinomycin D(+) cells and SYTO16(low) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725720     DOI: 10.1111/j.1537-2995.2007.01327.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children.

Authors:  Meghann Pine McManus; Li Wang; Cassie Calder; Becky Manes; Misty Evans; Kathryn Bruce; Richard H Ho; Jennifer Domm; Haydar Frangoul
Journal:  Pediatr Transplant       Date:  2012-04-26

2.  Cord blood-circulating endothelial progenitors for treatment of vascular diseases.

Authors:  M Lavergne; V Vanneaux; C Delmau; E Gluckman; I Rodde-Astier; J Larghero; G Uzan
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.

Authors:  Eiman Hussein; Todd DeFor; John E Wagner; Darin Sumstad; Claudio G Brunstein; David H McKenna
Journal:  Transfusion       Date:  2019-11-22       Impact factor: 3.157

Review 4.  The role and potential of umbilical cord blood in an era of new therapies: a review.

Authors:  Santiago Roura; Josep-Maria Pujal; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  Stem Cell Res Ther       Date:  2015-07-02       Impact factor: 6.832

5.  [The induction and cryopreservation of erythroid progenitor cells derived from umbilical cord blood mononuclear cells].

Authors:  Lin Chen; Xiaoyan Xie; Jiafei Xi; Yang Lyu; Yu Tian; Daqing Liu; Wen Yue; Yanhua Li; Xue Nan; Siting Li; Zeng Fan; Xuetao Pei
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.